Bruce F Bell

Array ( [id] => 6610103 [patent_doc_number] => 20020015884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Ionic liquids II' [patent_app_type] => new [patent_app_number] => 09/877259 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5524 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015884.pdf [firstpage_image] =>[orig_patent_app_number] => 09877259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546479 [patent_doc_number] => 20020137779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes' [patent_app_type] => new [patent_app_number] => 09/875514 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7485 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137779.pdf [firstpage_image] =>[orig_patent_app_number] => 09875514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1374457 [patent_doc_number] => 06562854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-13 [patent_title] => 'Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders' [patent_app_type] => B2 [patent_app_number] => 09/874412 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37307 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562854.pdf [firstpage_image] =>[orig_patent_app_number] => 09874412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460152 [patent_doc_number] => 06391908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Oxime amide indole type sPLA2 inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/856942 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391908.pdf [firstpage_image] =>[orig_patent_app_number] => 09856942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064250 [patent_doc_number] => 20020032226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Novel form of an oxazole compound' [patent_app_type] => new [patent_app_number] => 09/866362 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4466 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032226.pdf [firstpage_image] =>[orig_patent_app_number] => 09866362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578809 [patent_doc_number] => 06448271 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Substituted benzimidazoles and their use as parp inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/856686 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10828 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 988 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448271.pdf [firstpage_image] =>[orig_patent_app_number] => 09856686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889654 [patent_doc_number] => 20010025109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use' [patent_app_type] => new [patent_app_number] => 09/860568 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8256 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025109.pdf [firstpage_image] =>[orig_patent_app_number] => 09860568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 127944 [patent_doc_number] => RE041254 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-04-20 [patent_title] => 'Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds' [patent_app_type] => reissue [patent_app_number] => 11/723856 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 1837 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041254.pdf [firstpage_image] =>[orig_patent_app_number] => 11723856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040759 [patent_doc_number] => 06870057 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds' [patent_app_type] => utility [patent_app_number] => 10/276719 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 1836 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/870/06870057.pdf [firstpage_image] =>[orig_patent_app_number] => 10276719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1300503 [patent_doc_number] => 06624186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'Ion channel modulating agents comprising novel benzimidazolone derivatives' [patent_app_type] => B2 [patent_app_number] => 09/854357 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8747 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624186.pdf [firstpage_image] =>[orig_patent_app_number] => 09854357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987378 [patent_doc_number] => 20010036957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Method for prophylaxis and treatment of diabetic complications with 4[alpha-hydroxy-2-methyl-5(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives' [patent_app_type] => new [patent_app_number] => 09/850000 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5005 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036957.pdf [firstpage_image] =>[orig_patent_app_number] => 09850000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889331 [patent_doc_number] => 20020013356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'New polycyclic indanylimidazoles with alpha2 adrenergic activity' [patent_app_type] => new [patent_app_number] => 09/849540 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9827 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013356.pdf [firstpage_image] =>[orig_patent_app_number] => 09849540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460139 [patent_doc_number] => 06391905 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Condensed 4,5,6,7-tetrahydrobenzoCthiopenes as enhancer for cell differentiation induction factor action' [patent_app_type] => B1 [patent_app_number] => 09/847416 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 23263 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391905.pdf [firstpage_image] =>[orig_patent_app_number] => 09847416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889656 [patent_doc_number] => 20010025111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Substituted 3,3-diamino-2-propenenitriles, their preparation and use' [patent_app_type] => new [patent_app_number] => 09/848054 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14718 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025111.pdf [firstpage_image] =>[orig_patent_app_number] => 09848054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948143 [patent_doc_number] => 20010021780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Pharmaceutical composition containing bicyclic type compounds' [patent_app_type] => new [patent_app_number] => 09/846730 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8323 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021780.pdf [firstpage_image] =>[orig_patent_app_number] => 09846730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073813 [patent_doc_number] => 06838478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Amino acid derivatives and their use as thrombin inhibitors' [patent_app_type] => utility [patent_app_number] => 09/844427 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36077 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838478.pdf [firstpage_image] =>[orig_patent_app_number] => 09844427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446954 [patent_doc_number] => 06369089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Interheteroaryl 7-oxabicyclic 2.2.1heptane oxazoles as prostaglandin F2 antagonists' [patent_app_type] => B1 [patent_app_number] => 09/840675 [patent_app_country] => US [patent_app_date] => 2001-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6142 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369089.pdf [firstpage_image] =>[orig_patent_app_number] => 09840675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131963 [patent_doc_number] => 20020077455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Protease inhibitors' [patent_app_type] => new [patent_app_number] => 09/839410 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57007 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077455.pdf [firstpage_image] =>[orig_patent_app_number] => 09839410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440368 [patent_doc_number] => 06495569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Imidazolidine compounds' [patent_app_type] => B1 [patent_app_number] => 09/838657 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11686 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 447 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495569.pdf [firstpage_image] =>[orig_patent_app_number] => 09838657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575171 [patent_doc_number] => 06469002 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Imidazolidine compounds' [patent_app_type] => B1 [patent_app_number] => 09/838551 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19872 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 600 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469002.pdf [firstpage_image] =>[orig_patent_app_number] => 09838551 [rel_patent_id] =>[rel_patent_doc_number] =>)